XBP1 and Miyoshi myopathy: We isolated CD138+ MM cells from patients with active disease and found that XBP1 splicing was significantly inhibited by doxorubicin at 1 μM (Fig. 4C), which is within the previously reported cytotoxic dose range of this drug against human leukemic cells27.